Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04152694 · ClinicalTrials.gov registry record · Phase 4
Ceftaroline Pharmacokinetics in Continuous Renal Replacement Therapy
A Phase 4 study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- Phase 4
- Development phase
- 4
- Enrollment target
NCT04152694 is a Phase 4 study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 4 participants.
The verdict
NCT04152694, a Phase 4 study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 4 participants
- Enrollment target
Study Summary
Dosing of ceftaroline in patients with chronic kidney disease is defined, but there is no data on pharmacokinetics and pharmacodynamics of the drug in patients receiving continuous renal replacement therapy (CRRT). The purpose of this study is to determine pharmacokinetics and pharmacodynamics of ceftaroline in a critically ill patient population receiving CRRT, in order to define a dosing recommendation in this population.
Interventions
- OTHER Ceftaroline levels in CRRT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2018-03-09 |
| Est. Completion | 2020-09-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04152694
The ClinicalTrials.gov registry entry for NCT04152694 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ceftaroline levels in CRRT is the first listed.
NCT04152694 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04152694 about?
NCT04152694 is a clinical study titled "Ceftaroline Pharmacokinetics in Continuous Renal Replacement Therapy". Dosing of ceftaroline in patients with chronic kidney disease is defined, but there is no data on pharmacokinetics and pharmacodynamics of the drug in patients receiving continuous renal replacement therapy (CRRT). The purpose of this study is to determine pharmacokinetics and pharmacodynamics of ce...
What is the current status of trial NCT04152694?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 4 participants. The study started on 2018-03-09. Estimated completion is 2020-09-01.
What interventions are being tested in trial NCT04152694?
The interventions under investigation include: Ceftaroline levels in CRRT (OTHER).
Who is sponsoring clinical trial NCT04152694?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.